Briefing Room

Share

Associate Professor Patricia Zettler quoted in EndPoints News article discussing FDA commissioner

April 5, 2021 | Media News

An expert in the area of health law, Associate Professor Patricia Zettler was recently quoted in an article by EndPoints News titled, “Why the Biden administration might not want to be content with just an acting FDA commissioner.”

“Especially with an acting commissioner as experienced at the Agency as Dr. Woodcock is, I don’t think that having an acting commissioner should, as a practical matter, hold up things like routine guidance documents [one new guidance has been released since Biden took office], and we’ve seen the agency take some interesting steps, like announcing the April advisory committee meeting to review six oncology indications granted accelerated approval,” Zettler said. “That said, it might mean the Agency is less able or less willing to begin or announce new, broad initiatives.”